Neither use of bevacizumab, location of the primary tumor in the rectum, or metastatic disease burden were associated with increased interventionrate.
是否使用贝伐单抗、原发肿瘤的位置以及转移病灶的负荷均与干预措施的频率无关。
2
Results The interventionrate of cardiovascular disease was77%, control rate of 20%, regular medication 63%, blood pressure levels and cholesterol level decreased after treatment significantly;